Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00397566
Status:
WITHDRAWN
Last Update Posted:
2012-04-27
First Post:
2006-11-08
Brief Title:
A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Study Overview
Official Title:
Randomized Placebo-Controlled Ascending Multiple Dose Study to Evaluate the Safety Pharmacokinetics and Pharmacodynamics of BMS-707035 in HIV-1 Infected Subjects
Status:
WITHDRAWN
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this clinical research study is to assess the safety pharmacokinetics and pharmacodynamics of BMS-707035 in subjects infected with HIV-1
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None